Paul Gosar
The Public Record
Paul Anthony Gosar is an American politician and dentist serving as the U.S. Representative for Arizona's 4th congressional district since 2013. A member of the Republican Party, Gosar has been involved in various legislative efforts and has taken positions on issues such as wildlife management and economic policies affecting rural communities. He has been a vocal advocate for his constituents, often addressing concerns related to agriculture and land use in Arizona. Gosar has also been known for his controversial statements and positions on various national issues.
I find it very interesting that we are talking about tens of billions of dollars, and yet they cite 100 percent failure in prevailing wage accuracy that could save, if we had better accuracy on the prevailing wage, tens of billions of…
Clearly, science has taken a back seat to ideology with this administration--THAT NEEDS TO BE CORRECTED NOW.
THIS IS, IN MY EYES, AN OPEN ACT OF CONTEMPT OF CONGRESS AND THOSE RESPONSIBLE NEED TO BE HELD ACCOUNTABLE.
This bill recognizes that reality and builds into place critical reforms to sell off the helium in a much more responsible manner.
I am pleased that, by bipartisan negotiation and a focus on market principles, Ranking Member Markey and I have developed a bipartisan plan, The Responsible Helium Administration and Stewardship Act, which is H.R. 527, to address the…
This is critical mass. It's not just with pharmaceuticals but also our medical devices.
What other assets do we have there? I mean, this is critical mass that can turn money very, very quickly.
I don't think that the--the hypothesis or the conclusions you've come to are real.
I find that disdainful. This is an instant turnaround of quickly $80 million. And we shouldn't be building unless we actually know what we have as an inventory and make sure that we're selling it.
I think part of our problem--I'm looking here at a drug recall, or a drug-in-stock affidavit as of yesterday.
Do you think that your recommendations to the FDA are sufficient to mitigate this problem?
Seems to me like what we're doing here, is we're--we have a disease here, and what we're doing with this report is we're treating the symptoms but we're not treating the disease.
I do not think that what you have put out here in your outlines are suitable for reform.
I think there is also you can label this in we tend to be politically correct. A lot of this is theft, point blank theft.





